Cipla to acquire Inzpera Healthsciences for ₹110 crore
after close1 source ↓written by the desknot a recommendation
- in Inzpera Healthsciences
- 100% stake
- after working capital
- ₹110.65 crore
- for FY 2024-25
- ₹26.75 crore
Cipla Ltd will acquire a 100% stake in Inzpera Healthsciences for ₹110.65 crore after working capital adjustments. This strategic move aims to enhance Cipla's distribution network and operational capabilities in the paediatric segment. Inzpera reported a turnover of ₹26.75 crore for FY 2024-25, indicating growth potential.
Not investment advice. For informational purposes only.